XML 24 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 7 - Stock-based Compensation
3 Months Ended
Mar. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
7
.     
Stock-based Compensation
 
We recognize compensation expense for share-based payment awards made to our employees, consultants and directors. Our current stock-based compensation plans include our
2017
Equity and Incentive Compensation Plan (the
“2017
EICP”); our
2007
Long-Term Incentive Plan, as amended (the
“2007
Incentive Plan”); and our Directors’ Restricted Stock Plan. The following table provides our stock-based compensation expense and related income tax benefit for the
three
-months ended
March 31, 2018
and
2017,
respectively (in thousands).
 
   
Three Months Ended March 31,
 
   
2018
   
2017
 
Stock-based compensation expense, gross
  $
2,157
    $
1,337
 
Income tax benefit at our statutory rate associated with stock-based compensation
   
(548
)    
(521
)
Stock-based compensation expense, net
  $
1,609
    $
816
 
 
All shares of common stock and Class A common stock underlying outstanding options, restricted stock units and performance awards are counted as issued at target levels under the
2017
EICP, the
2007
Incentive Plan and the Directors’ Restricted Stock Plan for purposes of determining the number of shares available for future issuance.
 
During the
three
-months ended
March 31, 2018,
we granted under the
2017
EICP:
 
 
110,040
shares of restricted Class A common stock with a grant date fair value per share of
$12.65
to an employee, of which
36,680
shares will vest on each of
February 28, 2019,
2020
and
2021;
 
 
110,040
shares of restricted Class A common stock with a grant date fair value per share of
$12.65
to an employee, subject to the achievement of certain performance measures, which will vest on
February 28, 2021;
and
 
 
318,196
shares of restricted common stock with a grant date fair value per share of
$15.25
to certain employees, of which
153,406
shares will vest on
February 28, 2019,
82,394
shares will vest on
February 28, 2020,
and
82,396
shares will vest on
February 28, 2021.
 
During the
three
-months ended
March 31, 2017,
we granted under the
2007
Incentive Plan:
 
 
307,943
shares of restricted common stock to certain employees, of which
102,648
shares vested on
January 31, 2018;
102,648
shares will vest on
January 31, 2019;
and
102,647
shares will vest on
January 31, 2020;
and
 
 
198,220
shares of restricted Class A common stock to an employee, of which
66,073
shares vested on
January 31, 2018
and
66,073
shares will vest on
January 31, 2019;
and
66,074
shares will vest on
January 31, 2020.
 
A summary of restricted common stock and Class A common stock activities for the
three
-months ended
March 31, 2018
and
2017,
respectively, is as follows:
 
   
Three Months Ended
 
   
March 31, 2018
   
March 31, 2017
 
   
 
 
 
 
Weighted-
   
 
 
 
 
Weighted-
 
   
 
 
 
 
Average
   
 
 
 
 
Average
 
   
Number
   
Grant Date
   
Number
   
Grant Date
 
   
of
   
Fair Value
   
of
   
Fair Value
 
   
Shares
   
Per Share
   
Shares
   
Per Share
 
Restricted common stock:
                               
Outstanding - beginning of period
   
503,685
    $
11.14
     
396,033
    $
12.06
 
Granted
   
318,196
    $
15.25
     
307,943
    $
10.40
 
Vested
   
(225,570
)   $
11.21
     
(200,291
)   $
11.82
 
Outstanding - end of period
   
596,311
    $
13.31
     
503,685
    $
11.14
 
                                 
Restricted Class A common stock:
                               
Outstanding - beginning of period
   
462,632
    $
10.63
     
415,082
    $
10.15
 
Granted (1)
   
220,080
    $
12.65
     
198,220
    $
10.60
 
Vested
   
(274,926
)   $
10.48
     
(227,526
)   $
10.00
 
Outstanding - end of period
   
407,786
    $
11.82
     
385,776
    $
10.47
 
                                 
Restricted stock units - common stock:
                               
Outstanding - beginning of period
   
209,500
    $
15.70
     
 
     
 
 
Granted
   
-
    $
-
     
 
     
 
 
Vested
   
(209,500
)   $
15.70
     
 
     
 
 
Forfeited
   
-
    $
-
     
 
     
 
 
Outstanding - end of period
   
-
    $
-
     
 
     
 
 
 
(
1
)     For awards subject to future performance conditions, amounts assume target performance.
 
At
March 31, 2018
and
December 31, 2017,
we had
274,746
options to acquire our common stock outstanding, all of which were vested and exercisable. The exercise price of all outstanding stock options is
$1.99
per share. As of
March 31, 2018
and
December 31, 2017,
we did
not
have any options outstanding for our Class A common stock. The aggregate intrinsic value of our outstanding stock options was
$2.9
million based on the closing market price of our common stock on
March 31, 2018.